Insight Molecular Diagnostics (IMDX) vs XWELL (XWEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Insight Molecular Diagnostics is the larger company by market cap ($110.3 million vs $8.2 million), about 13.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMDX | XWEL |
|---|---|---|
| Share price | $3.37 | $0.8215 |
| Market cap | $110.28M | $8.19M |
| 1-day change | +2.74% | -10.60% |
| YTD return | -55.07% | — |
| 1-year return | -11.32% | — |
| 5-year return | -95.04% | — |
| EPS (TTM) | $-1.56 | $-5.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.51 | $2.20 |
| 52-week low | $2.42 | $0.26 |
| Distance from 52-week high | -60.40% | -62.66% |
| Analyst consensus | none | — |
| Avg. price target upside | +144.81% | — |
| Average volume | 232.87K | 35.96K |
| Shares outstanding | 32.72M | 9.97M |
| Employees | 55 | 175 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Other Consumer Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Insight Molecular Diagnostics is about 13.5 times larger than XWELL by market value ($110.28M vs $8.19M).
- The two companies sit in different sectors: Insight Molecular Diagnostics in Health Care and XWELL in Consumer Discretionary.
About Insight Molecular Diagnostics
IMDX stock →Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 55 employees
About XWELL
XWEL stock →XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally.
Consumer Discretionary · Other Consumer Services · 175 employees
IMDX vs XWEL FAQ
Which is bigger, Insight Molecular Diagnostics or XWELL?
Insight Molecular Diagnostics (IMDX) is larger, with a market capitalization of $110.28M compared with $8.19M for XWELL (XWEL).
Are Insight Molecular Diagnostics and XWELL in the same industry?
No. Insight Molecular Diagnostics is in the Health Care sector, while XWELL is in Consumer Discretionary.